[获得性活化蛋白C抵抗：激素治疗及血浆VIII因子水平升高的潜在作用] - Suppr | 超能文献

[Activated protein C resistance of an acquired nature: the potential role of hormonal treatment and of elevated factor VIII plasma levels].

作者信息

Iturbe Hernández T, Varo M J, Olave M T, Fuertes M A, Cornudella R

出版信息

Rev Clin Esp. 1999 Sep;199(9):618.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Activated protein C resistance of an acquired nature: the potential role of hormonal treatment and of elevated factor VIII plasma levels].[获得性活化蛋白C抵抗：激素治疗及血浆VIII因子水平升高的潜在作用]

Rev Clin Esp. 1999 Sep;199(9):618.

2

Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal women.口服和经皮雌激素替代疗法对与静脉血栓形成相关的止血变量的影响：一项针对绝经后女性的随机、安慰剂对照研究。

Arterioscler Thromb Vasc Biol. 2003 Jun 1;23(6):1116-21. doi: 10.1161/01.ATV.0000074146.36646.C8. Epub 2003 May 1.

3

Thyroid function, activated protein C resistance and the risk of venous thrombosis in users of hormonal contraceptives.激素避孕药使用者的甲状腺功能、活化蛋白C抵抗与静脉血栓形成风险

Thromb Res. 2014 Apr;133(4):640-4. doi: 10.1016/j.thromres.2013.12.041. Epub 2014 Jan 7.

4

Activated protein C resistance due to factor V Leiden, elevated coagulation factor VIII and postoperative deep vein thrombosis in late breast reconstruction with a free TRAM flap: a report of two cases.因凝血因子V莱顿突变导致的活化蛋白C抵抗、凝血因子VIII升高与游离腹直肌肌皮瓣晚期乳房重建术后深静脉血栓形成：两例报告

Br J Plast Surg. 2005 Jul;58(5):720-3. doi: 10.1016/j.bjps.2004.12.024.

5

Changes of hemostatic variables during oral contraceptive use.口服避孕药使用期间止血变量的变化。

Semin Vasc Med. 2003 Feb;3(1):61-8. doi: 10.1055/s-2003-38333.

6

Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system.传统及低剂量口服激素疗法（HT）、替勃龙和雷洛昔芬对活化蛋白C系统功能的不同影响。

Thromb Haemost. 2007 Jun;97(6):938-43.

7

The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI.不同激素避孕药对血浆游离蛋白 S 和游离 TFPI 水平的影响。

Thromb Haemost. 2013 Apr;109(4):606-13. doi: 10.1160/TH12-10-0771. Epub 2013 Feb 14.

8

[Oral contraceptives and activated protein C resistance: a paradigmatic example of genotype and environment interaction in the development of deep venous thrombosis].[口服避孕药与活化蛋白C抵抗：深静脉血栓形成中基因型与环境相互作用的典型实例]

Clin Ter. 1999 Nov-Dec;150(6):445-7.

9

Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals.血栓形成患者和对照个体中ABO及分泌型基因型与血浆VIII因子和血管性血友病因子水平的关系。

Br J Haematol. 2005 Jan;128(1):100-7. doi: 10.1111/j.1365-2141.2004.05249.x.

10

[Hormone therapy and risk of venous thromboembolism: new insights from the ESTHER study].[激素治疗与静脉血栓栓塞风险：ESTHER研究的新见解]

Med Sci (Paris). 2008 Mar;24(3):228-31. doi: 10.1051/medsci/2008243228.